Differential responses of circadian activity onset and offset following GABA-ergic and opioid receptor activation.
The circadian pacemaker in the mammalian suprachiasmatic nuclei is responsive to photic and nonphotic stimuli. In the present study, the authors have investigated the response of activity onset and offset to application of nonphotic stimuli: the benzodiazepine midazolam and the opioid receptor agonist fentanyl. In correspondence with previous studies, both stimuli induced phase advances of the activity onset when given in the mid- to late subjective day. In contrast, activity offset did not phase advance following these injections. Injections during the early subjective day induced small phase delays of the activity onset, while large phase delays occurred in activity offset. Phase shifts, induced at both circadian time zones, were paralleled by an increase in the length of daily activity (alpha). The increase in a remained present during several days after the injection. The different kinetics in phase shifting of the activity onset and offset indicate complexity in phase-shifting behavior of the circadian pacemaker in response to nonphotic stimuli. Moreover, the data show responsiveness of the circadian system to GABA-ergic and opioid receptor activation, not only during the mid- to late subjective day but also during the early subjective day. The data implicate that the early subjective day is an interesting phase for analysis of molecular and biochemical processes involved in nonphotic phase shifting.
Vansteensel
Mariska J
MJ
Department of Neurophysiology, Leiden University Medical Center, P.O. Box 9604, 2300 RC Leiden, The Netherlands.
Deboer
Tom
T
Dahan
Albert
A
Meijer
Johanna H
JH
D000204:Activity Cycles / Q000187:drug effects; D000818:Animals; D002940:Circadian Rhythm / Q000187:drug effects* / Q000502:physiology*; D006224:Cricetinae; D005283:Fentanyl / Q000494:pharmacology; D018755:GABA Agonists / Q000494:pharmacology*; D008297:Male; D008647:Mesocricetus; D008874:Midazolam / Q000494:pharmacology; D018079:Receptors, GABA / Q000378:metabolism*; D011957:Receptors, Opioid / Q000819:agonists* / Q000378:metabolism; D012965:Sodium Chloride / Q000494:pharmacology; D013493:Suprachiasmatic Nucleus / Q000187:drug effects / Q000502:physiology
D018755:GABA Agonists; D018079:Receptors, GABA; D011957:Receptors, Opioid; D012965:Sodium Chloride; D008874:Midazolam; D005283:Fentanyl